Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Sponsor: Staci Gruber, Ph.D.
Summary
Despite recent increases in both medical and recreational cannabis use in the United States and globally, little research has been conducted to determine the potential applications for womens health. A variety of medical cannabis and hemp-derived products on the marketplace claim to hold efficacy for many womens health-related conditions, including gynecologic pain. This 7-day study of individuals living with endometriosis, adenomyosis, or chronic pelvic inflammatory disease (PID), will identify specific targets and mechanisms underlying the potential impact of a hemp-derived, full-spectrum, high-CBD product in individuals with gynecologic pain.
Official title: PAIN-GP: Project Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Key Details
Gender
FEMALE
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-09
Completion Date
2029-01
Last Updated
2026-07-27
Healthy Volunteers
No
Interventions
Custom-formulated, high-CBD study product
2 doses of the high-CBD study product will be used, compared to placebo.
Placebo
Placebo study product.
Locations (1)
McLean Hospital
Belmont, Massachusetts, United States